Literature DB >> 15833851

The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.

Sonata Jodele1, Christophe F Chantrain, Laurence Blavier, Carolyn Lutzko, Gay M Crooks, Hiroyuki Shimada, Lisa M Coussens, Yves A Declerck.   

Abstract

The contribution of the tumor stroma to cancer progression has been increasingly recognized. We had previously shown that in human neuroblastoma tumors orthotopically implanted in immunodeficient mice, stromal-derived matrix metalloproteinase-9 (MMP-9) contributes to the formation of a mature vasculature by promoting pericyte recruitment along endothelial cells. Here we show that MMP-9 is predominantly expressed by bone marrow-derived CD45-positive leukocytes. Using a series of bone marrow transplantation experiments in MMP-9(+/+) and MMP-9(-/-) mice xenotransplanted with human neuroblastoma tumors, we show that bone marrow-derived MMP-9 is critical for the recruitment of leukocytes from bone marrow into the tumor stroma and for the integration of bone marrow-derived endothelial cells into the tumor vasculature. Expression of MMP-9 by bone marrow-derived cells in the tumor stroma is also critical for the formation of a mature vasculature and coverage of endothelial cells with pericytes. Furthermore, in primary human neuroblastoma tumor specimens of unfavorable histology, we observed a higher level of tumor infiltration with MMP-9 expressing phagocytic cells and a higher degree of coverage of endothelial cells by pericytes when compared with tumor specimens with a favorable histology. Taken together, the data show that in neuroblastoma, MMP-9 plays a critical role in the recruitment of bone marrow-derived cells to the tumor microenvironment where they positively contribute to angiogenesis and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833851     DOI: 10.1158/0008-5472.CAN-04-3770

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  64 in total

1.  Adipose-derived stem cells increase angiogenesis through matrix metalloproteinase-dependent collagen remodeling.

Authors:  Young Hye Song; Seung Hee Shon; Mengrou Shan; Abraham D Stroock; Claudia Fischbach
Journal:  Integr Biol (Camb)       Date:  2016-01-13       Impact factor: 2.192

2.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Authors:  Mitomu Kioi; Hannes Vogel; Geoffrey Schultz; Robert M Hoffman; Griffith R Harsh; J Martin Brown
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

3.  Matrix metalloproteinase-9 and cell division in neuroblastoma cells and bone marrow macrophages.

Authors:  M Gloria Sans-Fons; Sonia Sole; Coral Sanfeliu; Anna M Planas
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 4.  Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.

Authors:  Megumi Iiizumi; Wen Liu; Sudha K Pai; Eiji Furuta; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2008-07-22

5.  Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.

Authors:  Cong Hua; Gang Zhao; Yan Feng; Hongyan Yuan; Hongmei Song; Li Bie
Journal:  J Neurotrauma       Date:  2015-08-06       Impact factor: 5.269

6.  Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages.

Authors:  Qi Hao; Jianrong Liu; Rajita Pappu; Hua Su; Radoslaw Rola; Rodney A Gabriel; Chanhung Z Lee; William L Young; Guo-Yuan Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-18       Impact factor: 8.311

7.  Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

Authors:  Saul J Priceman; James L Sung; Zory Shaposhnik; Jeremy B Burton; Antoni X Torres-Collado; Diana L Moughon; Mai Johnson; Aldons J Lusis; Donald A Cohen; M Luisa Iruela-Arispe; Lily Wu
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

8.  Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels.

Authors:  Krishna Reddy; Zhichao Zhou; Keri Schadler; Shu-Fang Jia; Eugenie S Kleinerman
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

9.  Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.

Authors:  Veronica C Ardi; Philippe E Van den Steen; Ghislain Opdenakker; Bernhard Schweighofer; Elena I Deryugina; James P Quigley
Journal:  J Biol Chem       Date:  2009-07-16       Impact factor: 5.157

10.  Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors.

Authors:  Yonatan Y Mahller; Sachin S Vaikunth; Maria C Ripberger; William H Baird; Yoshinaga Saeki; Jose A Cancelas; Timothy M Crombleholme; Timothy P Cripe
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.